Serial Number
99637741
Owner
RE18 Health Ventures Inc.Attorney
Sarah Anne KeefeFiling Date
Feb 6, 2026
Serial #99637741 Trademark
Serial Number: 99637741
Trademark Classes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Sarah Anne Keefe Womble Bond Dickinson (US) LLP
470 Atlantic Avenue, Suite 600
Boston, MA 02210
United States
Trademark Details
Filing Date
February 6, 2026
Registration Date
Not Registered
Published for Opposition
June 30, 2026
Goods & Services
Medical services for the diagnosis of diseases of the human body; medical examination of persons; medical tele-reporting being medical services; medical imaging services; medical analysis services in connection with the treatment of persons provided by a medical laboratory; medical analysis services for diagnostic and therapeutic purposes provided by medical laboratories; medical testing services in connection with the diagnosis and treatment of diseases; provision of reports in connection with medical examinations of persons
Downloadable computer operating programs used in the health care and medical field; downloadable computer application software for data processing and hardware, in the field of diagnostic and health care services; downloadable computer software for facilitating electronic commerce relating to diagnostic and health care services in the nature of providing consulting services; downloadable machine learning software for health care consulting; computer hardware for health care consulting services
Scientific research for medical purposes; provision of information in relation to scientific research in the field of biochemistry; scientific laboratory services; research and development services in the field of cytology and nosology; none of the aforementioned services in the pharmaceutical field and/or for the development of medicines